Our data underline the relevance of ETV6-fusion proteins in the development of undifferentiated T-ALL and support the use of genomic breakpoints within ETV6 as potential MRD markers for (near) ETP-ALL that otherwise lack clonal markers. The gene discussed is ETV6; the disease is acute lymphoblastic leukemia.